Rachael Ward

Rachael Ward is a seasoned professional in the field of neuroscience and regulatory affairs, currently serving as a Regulatory Affairs Specialist and Scientist for Biologicals at the Berlin Institute of Health since June 2024. Previously, Rachael held the position of Assistant Director at AudioCure Pharma GmbH, focused on developing innovative pharmaceutical therapies for inner ear disorders from June 2012 to May 2024. Rachael's academic background includes a PhD in Neuroscience from Queen Mary University of London, complemented by research experience as a Career Development Fellow at MRC and postdoctoral researcher at Queen Mary University. Rachael's early career involved significant roles at GlaxoSmithKline and Eli Lilly, where pharmacokinetics and behavioral testing in drug development were key focus areas.